Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 16,988 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
6,164
6,164
5,810
5,549
5,215
5,212
Revenue Growth (YoY)
6%
6%
5%
6%
0%
14%
Cost of Revenue
1,972
1,972
1,731
1,654
1,514
1,507
Gross Profit
4,192
4,192
4,079
3,895
3,701
3,705
Selling, General & Admin
2,685
2,685
2,671
2,646
2,555
2,438
Research & Development
296
296
288
299
300
310
Operating Expenses
3,157
3,157
3,189
3,190
3,067
2,985
Other Non Operating Income (Expenses)
-16
-16
-28
-1
0
-9
Pretax Income
779
779
498
290
235
586
Income Tax Expense
154
154
86
27
12
62
Net Income
625
625
412
263
223
524
Net Income Growth
52%
52%
56.99%
18%
-56.99%
17%
Shares Outstanding (Diluted)
865.93
872.9
876
873
874.5
878
Shares Change (YoY)
-1%
0%
0%
0%
0%
0%
EPS (Diluted)
0.71
0.71
0.47
0.3
0.25
0.59
EPS Growth
52%
52%
56%
18%
-56.99%
17%
Free Cash Flow
852
852
606
181
110
469
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
68%
68%
70.2%
70.19%
70.96%
71.08%
Operating Margin
16.79%
16.79%
15.31%
12.7%
12.15%
13.81%
Profit Margin
10.13%
10.13%
7.09%
4.73%
4.27%
10.05%
Free Cash Flow Margin
13.82%
13.82%
10.43%
3.26%
2.1%
8.99%
EBITDA
1,608
1,608
1,535
1,388
1,251
1,287
EBITDA Margin
26.08%
26.08%
26.41%
25.01%
23.98%
24.69%
D&A For EBITDA
573
573
645
683
617
567
EBIT
1,035
1,035
890
705
634
720
EBIT Margin
16.79%
16.79%
15.31%
12.7%
12.15%
13.81%
Effective Tax Rate
19.76%
19.76%
17.26%
9.31%
5.1%
10.58%
Follow-Up Questions
What are Smith & Nephew plc's key financial statements?
According to the latest financial statement (Form-10K), Smith & Nephew plc has a total asset of $10,457, Net profit of $625
What are the key financial ratios for SNN?
Smith & Nephew plc's Current ratio is 2.02, has a Net margin is 10.13, sales per share of $7.06.
How is Smith & Nephew plc's revenue broken down by segment or geography?
Smith & Nephew plc largest revenue segment is Avon Protection, at a revenue of 114,876,851 in the most earnings release.For geography, United States is the primary market for Smith & Nephew plc, at a revenue of 183,834,522.
Is Smith & Nephew plc profitable?
yes, according to the latest financial statements, Smith & Nephew plc has a net profit of $625
Does Smith & Nephew plc have any liabilities?
yes, Smith & Nephew plc has liability of 5,168
How many outstanding shares for Smith & Nephew plc?
Smith & Nephew plc has a total outstanding shares of 849.76